查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623479

全球植入式藥物傳輸設備市場規模：依產品、應用、技術、最終用戶、地區劃分的範圍及預測

Global Implantable Drug Delivery Devices Market Size By Product, By Application, By Technology, By End-User And By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

植入式藥物輸送裝置的市場規模及預測

植入式藥物輸送設備市場規模預計在 2023 年達到 255.2 億美元，預計在 2024 年至 2031 年期間的複合年增長率為 7.25%，到 2031 年將達到 403.5 億美元。 據預測。允許特定部位給藥的可植入藥物輸送裝置是一種能夠有效輸送低濃度藥物的替代系統。此功能可提高患者的依從性，同時最大限度地減少潛在的副作用。這些裝置有助於治療劑的持續釋放，無需反覆針刺即可注射藥物或液體。植入式藥物輸送裝置避免了因靜脈注射而住院的現象。

這些裝置由被聚合物或藥物-聚合物混合物包圍的藥物儲存器組成，被插入體內的所需部位，聚合物在此降解，並以預定的速率釋放藥物。

植入式藥物傳輸裝置的全球市場動態

影響植入式藥物傳輸設備市場的關鍵市場動態

主要市場驅動因子

慢性病發生率不斷上升：

由於人口老化、不健康的生活方式和診斷方法的改進等因素，癌症、心血管疾病和糖尿病等慢性疾病在世界各地變得越來越普遍。日益加重的負擔推動了對有效治療方案的需求，而植入式藥物傳輸系統已成為控制和標靶藥物釋放的寶貴工具。

技術進步：

材料科學、微加工和生物工程的不斷進步正在推動更複雜和有效的植入式藥物輸送裝置的發展。這些進步可以實現控製藥物釋放、改善生物相容性和標靶輸送等功能，最終改善患者的治療效果並推動市場成長。

越來越重視微創手術：

由於恢復時間更快、患者不適感更少，人們更傾向於選擇微創手術而非傳統手術，這是推動植入式藥物傳輸市場發展的主要因素。這些設備提供了一種微創的替代傳統藥物輸送方法，例如口服藥物和注射，使其成為患者和醫療保健提供者都具有吸引力的選擇。

主要問題

嚴格的監理要求：

由於體內植入異物有固有風險，因此植入式藥物輸送系統的核准程序受到嚴格監管。這需要嚴格的測試和臨床試驗以確保安全性、有效性和生物相容性，從而導致漫長而昂貴的開發時間。這可能會嚴重阻礙創新並延遲向患者提供救命的治療。

開發及製造成本高：

由於涉及的技術複雜，並且需要高品質的材料和先進的製造工藝，植入式藥物傳輸系統的開發和製造成本通常很高。這將要求大公司承擔大量的前期成本，這可能會影響獲利能力並限制獲得這些技術的機會，特別是對於中低收入國家的患者而言。

報銷課題與市場准入：

即使獲得監管部門批准，從保險公司和醫療保健提供者獲得這些先進療法的足夠報銷仍然很困難。這些限制可能會阻礙患者獲得可能改變生活的治療方法，並抑制植入式藥物傳輸系統市場的成長。此外，進入醫療保健體系和法規不同的地區市場對在該市場運營的公司也構成了另一個障礙。

主要趨勢

加強一體化與策略聯盟：

隨著大型製藥和醫療器材公司尋求透過合併、收購和策略聯盟來加強其地位，植入式藥物輸送市場也正在經歷整合。這些合作旨在利用互補的技術和專業知識來加速產品開發和上市。

探索擴充應用：

植入式藥物傳遞系統已被探索應用於傳統藥物傳遞以外的廣泛的醫療治療領域，包括荷爾蒙替代療法、疼痛管理、避孕和癌症治療。應用的多樣化正在推動市場創新和投資。

關注病人的便利性與依從性：

植入式藥物傳遞系統有可能消除頻繁給藥和服藥的需要，從而提高患者的依從性和便利性。這對於需要長期藥物治療的慢性病患者尤其有益。

目錄

第 1 章 植入式藥物輸送裝置的全球市場：簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第 4 章 植入式藥物輸送裝置的全球市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析
  • 監理框架

5. 全球植入式藥物傳輸設備市場（依技術劃分）

  • 概述
  • 主動藥物輸送裝置
  • 被動藥物輸送裝置
    • 可生物降解
    • 不可生物降解
第六章全球植入式藥物傳輸設備市場（依產品）
  • 概述
  • 生物可吸收支架
  • 避孕藥物輸送裝置
  • 眼內藥物輸送裝置
  • 冠狀動脈藥物洗脫支架
  • 近距離放射治療種子
  • 藥物輸液泵
第七章全球植入式藥物傳輸設備市場（依應用）
  • 概述
  • 心血管疾病
  • 腫瘤學
  • 糖尿病
  • 眼科
  • 自體免疫疾病
  • 避孕
  • 其他

8. 全球植入式藥物傳輸設備市場（依最終用戶劃分）

  • 概述
  • 醫院和診所
  • 門診手術中心
  • 專業中心
  • 其他

第 9 章。
  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 世界其他地區
    • 中東和非洲

第 10 章。
  • 概述
  • 各公司的市佔率
  • 供應商概況
  • 主要發展策略

第 11 章 公司簡介

  • Bayer
  • Boston Scientific
  • Medtronic
  • Merck & Co. Inc.
  • Allergan Inc.
  • Bausch And Lomb Inc.
  • Ithetis
  • Nucletron
  • Genetech Inc.
  • Theragenics

第 12 章 重大進展

  • 產品發佈/開發
  • 合併和收購
  • 業務擴展
  • 夥伴關係和合作關係

第 13 章附錄

  • 相關研究
簡介目錄
Product Code: 23845

Implantable Drug Delivery Devices Market Size And Forecast

Implantable Drug Delivery Devices Market size is estimated at USD 25.52 Billion in 2023 and is projected to reach USD 40.35 Billion by 2031, growing at a CAGR of 7.25% from 2024 to 2031. Implantable drug delivery devices, which enable site-specific drug administration, are an alternative system capable of achieving effective delivery with lower drug concentrations. This capability allows for the minimization of potential side effects while increasing patient compliance. The sustained release of a therapeutic agent is facilitated by these devices, which administer drugs and fluids without the need for the repeated insertion of needles. Hospitalization for intravenous infusion is avoided by implantable drug delivery devices.

Consisting of a drug reservoir surrounded by a polymer or a drug-polymer mixture, these devices release the drug at a pre-determined rate as the polymer degrades upon insertion into a desired area in the body.

Global Implantable Drug Delivery Devices Market Dynamics

The key market dynamics that are shaping the Implantable Drug Delivery Devices Market include:

Key Market Drivers

Rising Prevalence of Chronic Diseases:

Chronic diseases like cancer, cardiovascular diseases, and diabetes are increasingly prevalent worldwide, driven by factors such as an aging population, unhealthy lifestyles, and improved diagnostics. The demand for effective treatment options is fueled by this rising burden, making implantable drug delivery systems a valuable tool for controlled and targeted drug release, potentially improving treatment efficacy and patient compliance.

Technological Advancements:

Continuous advancements in materials science, microfabrication, and bioengineering are leading to the development of more sophisticated and effective implantable drug-delivery devices. Features like controlled drug release, improved biocompatibility, and targeted delivery are enabled by these advancements, ultimately leading to better patient outcomes and driving market growth.

Growing Focus on Minimally Invasive Procedures:

The increasing preference for minimally invasive procedures over traditional surgeries due to faster recovery times and less patient discomfort is a significant driver for the Implantable Drug Delivery Devices Market. These devices offer a minimally invasive alternative to traditional drug delivery methods like oral medications or injections, making them an attractive option for both patients and healthcare providers.

Key Challenges

Stringent Regulatory Requirements:

Due to the inherent risks associated with implanting foreign objects in the body, the approval process for implantable drug delivery systems is highly regulated. This involves subjecting them to rigorous testing and clinical trials to ensure safety, efficacy, and biocompatibility, resulting in lengthy and expensive development timelines. Innovation can be significantly impeded, and the availability of life-saving treatments to patients may be delayed as a consequence.

High Cost of Development and Production:

Implantable drug delivery systems often incur high costs in development and manufacturing due to the involvement of complex technologies and the necessity for high-quality materials and advanced manufacturing processes. This leads to substantial upfront costs for companies, impacting their profitability and potentially restricting access to these technologies for patients, particularly in low- and middle-income countries.

Reimbursement Challenges and Market Access:

Even following regulatory approval, securing adequate reimbursement from insurance companies and healthcare providers for these advanced therapies can be challenging. This limitation can impede patient access to these potentially life-changing treatments, thereby hindering market growth for implantable drug delivery systems. Additionally, gaining market access in different regions with varying healthcare systems and regulations presents another obstacle for companies operating in this market.

Key Trends

Consolidation Being Witnessed and Strategic Partnerships:

Consolidation was being witnessed in the Implantable Drug Delivery Devices Market as larger pharmaceutical and medical device companies were being sought to strengthen their positions through mergers, acquisitions, and strategic partnerships. These collaborations aimed to leverage complementary technologies and expertise to accelerate product development and market penetration.

Exploration of Expanding Applications:

Implantable drug delivery systems were being explored for a wide range of therapeutic applications beyond traditional drug delivery, including hormone replacement therapy, pain management, contraception, and cancer treatment. This diversification of applications was driving innovation and investment in the market.

Focus on Patient Convenience and Compliance:

The potential to improve patient compliance and convenience was offered by implantable drug delivery systems by eliminating the need for frequent dosing or administration. This was particularly beneficial for patients with chronic conditions who required long-term medication therapy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Implantable Drug Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the Implantable Drug Delivery Devices Market:

North America

A well-established healthcare infrastructure, including advanced medical facilities and research institutions, fosters innovation and the adoption of implantable drug delivery technologies.

Stringent regulatory standards, particularly by the FDA, ensure rigorous evaluation and approval processes for implantable drug delivery devices, enhancing confidence in their safety and efficacy.

Substantial investments in research and development are attracted by the region is facilitating the development of cutting-edge implantable drug delivery technologies and thereby, driving market growth.

The demand for effective and long-term drug delivery solutions is driven by the rising burden of chronic diseases such as cancer, cardiovascular diseases, and diabetes in North America, further solidifying the region's dominance in the market.

Asia Pacific

Market growth is driven by increasing healthcare expenditure in countries like China and India.

Demand for long-term drug delivery solutions is boosted by the rising prevalence of chronic diseases in the region.

Market expansion is contributed to by technological advancements and the growing adoption of innovative medical devices.

The market in Asia Pacific is further propelled by government initiatives to improve healthcare infrastructure and access to advanced treatments.

Global Implantable Drug Delivery Devices Market: Segmentation Analysis

The Global Implantable Drug Delivery Devices Market is Segmented on the basis of Product, Application, Technology, End-User, and Geography.

Implantable Drug Delivery Devices Market, By Product

  • Bio-absorbable stents
  • Contraceptive Drug Delivery Devices
  • Intraocular Drug Delivery Devices
  • Coronary Drug Eluting Stents
  • Brachytherapy Seeds
  • Drug Infusion Pumps

Based on Product, the market is segmented into Bio-absorbable stents, Contraceptive Drug Delivery Devices, Intraocular Drug Delivery Devices, Coronary Drug Eluting Stents, Brachytherapy Seeds, and Drug Infusion Pumps. The highest market share in the Implantable Drug Delivery Devices Market is held by the coronary drug-eluting stents segment. This dominance is primarily attributed to the widespread prevalence of cardiovascular diseases worldwide, resulting in a substantial demand for effective treatment options such as drug-eluting stents. Advancements in stent technologies and procedural techniques further contribute to the segment's market dominance.

Implantable Drug Delivery Devices Market, By Application

  • Cardiovascular Diseases
  • Oncology
  • Diabetes
  • Ophthalmology
  • Autoimmune Diseases
  • Birth Control & Contraception
  • Others

Based on Application, the market is segmented into Cardiovascular Diseases, Oncology, Diabetes, Ophthalmology, Autoimmune Diseases, Birth Control & Contraception, and Others. The highest market share in the Implantable Drug Delivery Devices Market is held by the cardiovascular diseases segment. This dominance is primarily attributed to the significant prevalence of cardiovascular conditions globally, which necessitates effective and targeted drug delivery solutions. The segment's market leadership is further contributed to by continuous advancements in cardiovascular therapies and procedures.

Implantable Drug Delivery Devices Market, By Technology

  • Active Drug Delivery Device
  • Passive Drug Delivery Device
  • Biodegradable
  • Non-biodegradable

Based on Technology, the market is segmented into Active Drug Delivery Devices and Passive Drug Delivery Devices. From which, Passive drug eluting device technology is projected to hold a major revenue share in the Implantable Drug Delivery Devices Market. This dominance of the segment is attributable to the large-scale applications of passive drug-eluting solutions in the fields of oncology, cardiology, pain management, contraception, etc.

Implantable Drug Delivery Devices Market, By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others

Based on End-User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Centers, and Others. The Implantable Drug Delivery Devices Market's highest market share is held by hospitals & clinics. This dominance is primarily attributed to the widespread utilization of these facilities for the diagnosis, treatment, and management of various medical conditions necessitating implantable drug delivery systems. Specialized departments and resources dedicated to implantable drug delivery within hospitals and clinics further contribute to their market leadership.

Key Players

  • The "Implantable Drug Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Bayer, Boston Scientific, Medtronic, Merck & Co., Inc., Allergan, Inc., Bausch AndLomb, Inc., Ithetis, Nucletron, Genetech, Inc., Theragenics, Psivida, Kinamed, Inc., K2M, Inc., Mako Surgical Corp., and Varian Medical System.

Our market analysis includes a section specifically devoted to such major players, where our analysts give an overview of each player's financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned players globally are also included in the competitive landscape section.

  • Implantable Drug Delivery Devices Market Recent Developments
  • In August 2022, the Onyx Frontier drug-eluting stent (DES) was launched by Medtronic, after receiving CE Mark approval. This stent features an innovative delivery system and is built upon the success of their previous DES products.
  • In February 2023, FDA approval was received by Boston Scientific for their Eluvia drug-eluting stent intended for the treatment of coronary artery disease. This stent employs a novel polymer designed to control drug release and potentially enhance patient outcomes.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Active Drug Delivery Device
  • 5.3 Passive Drug Delivery Device
    • 5.3.1 Biodegradable
    • 5.3.2 Non-biodegradable

6 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT

  • 6.1 Overview
  • 6.2 Bio-absorbable stents
  • 6.3 Contraceptive Drug Delivery Devices
  • 6.4 Intraocular Drug Delivery Devices
  • 6.5 Coronary Drug Eluting Stents
  • 6.6 Brachytherapy Seeds
  • 6.7 Drug Infusion Pumps

7 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Cardiovascular Diseases
  • 7.3 Oncology
  • 7.4 Diabetes
  • 7.5 Ophthalmology
  • 7.6 Autoimmune Diseases
  • 7.7 Birth Control & Contraception
  • 7.8 Others

8 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END-USER

  • 8.1 Overview
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Specialty Centers
  • 8.5 Others

9 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
  • 9.6 Rest of the World
    • 9.6.1 Middle East And Africa

10 GLOBAL IMPLANTABLE DRUG DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Share
  • 10.3 Vendor Landscape
  • 10.4 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Bayer
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Boston Scientific
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Medtronic
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Merck & Co. Inc.
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Allergan Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Bausch And Lomb Inc.
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Ithetis
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Nucletron
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Genetech Inc.
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 Theragenics
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research